National Vision Holdings Inc Overview
Industry: Specialty Retail
Sector: Consumer Cyclical
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. The company was founded in 1990 and is headquartered in Duluth, Georgia. National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyegl Read MoreMavefund brings filings, fundamentals, valuation, price history and news for National Vision Holdings Inc into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
Revenue was $543.9M (+6.6% YoY); EPS was $0.38 (reported).
What changed
- Revenue +6.6% YoY to $543.9M; EPS reported to $0.38.
- Operating income +34.4% YoY to $55.5M.
- Adjusted EBITDA +23% YoY to $78.7M.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
US FDA approves Outlook Therapeutics' eye disease drug
Headline from Reuters: US FDA approves Outlook Therapeutics' eye disease drug.
IBM shares rise 3% post-Q2 earnings miss as investors eye prior profit warning
Headline from Yahoo Finance: IBM shares rise 3% post-Q2 earnings miss as investors eye prior profit warning.
US start-up wins EU approval for sight-restoring bionic eye
Headline from Financial Times: US start-up wins EU approval for sight-restoring bionic eye.
FDA recall hits 2.5 million bottles of widely used eye drops
Headline from Yahoo Finance: FDA recall hits 2.5 million bottles of widely used eye drops.
Mike Santoli: Why eye-popping earnings expectations have failed to lift the market for two months
Headline from CNBC: Mike Santoli: Why eye-popping earnings expectations have failed to lift the market for two months.
China refiners snap up September Russian crude, eye Iranian oil as Mideast supply risks grow
Headline from Reuters: China refiners snap up September Russian crude, eye Iranian oil as Mideast supply risks grow.
Earnings Per Share
Return on Equity
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.